Deficits in spontaneous burrowing behavior in the rat bilateral monosodium iodoacetate model of osteoarthritis: an objective measure of pain-related behavior.

Slides:



Advertisements
Similar presentations
Efficacy of ultrasound therapy for the management of knee osteoarthritis: a systematic review with meta-analysis A. Loyola-Sánchez, J. Richardson, N.J.
Advertisements

C. R. Flannery, N. Moran, D. Blasioli, K. Donahue, J. Kane, T
Pharmacological interrogation of a rodent forced ambulation model: leveraging gait impairment as a measure of pain behavior pre-clinically  B.L. Adams,
B. J. Kim, D. -W. Kim, S. H. Kim, J. H. Cho, H. J. Lee, D. Y. Park, S
Cellular and histopathological changes in the infrapatellar fat pad in the monoiodoacetate model of osteoarthritis pain  K.M. Clements, A.D. Ball, H.B.
The importance of dose in land-based supervised exercise for people with hip osteoarthritis. A systematic review and meta-analysis  T. Moseng, H. Dagfinrud,
Monosodium iodoacetate-induced inflammation and joint pain are reduced in TRPA1 deficient mice – potential role of TRPA1 in osteoarthritis  L.J. Moilanen,
Long-term analgesic effect of a single dose of anti-NGF antibody on pain during motion without notable suppression of joint edema and lesion in a rat.
Dissecting the contribution of knee joint NGF to spinal nociceptive sensitization in a model of OA pain in the rat  D.R. Sagar, L. Nwosu, D.A. Walsh,
Paradoxical effects of the cannabinoid CB2 receptor agonist GW on rat osteoarthritic knee joint pain  N. Schuelert, C. Zhang, A.J. Mogg, L.M. Broad,
K. Koda, K. Hyakkoku, K. Ogawa, K. Takasu, S. Imai, Y. Sakurai, M
Short-term placebo response in trials of patients with symptomatic osteoarthritis: differences between hip and knee  S. Reiter-Niesert, M. Boers, J. Detert 
A short-term pharmacodynamic model for monitoring aggrecanase activity: injection of monosodium iodoacetate (MIA) in rats and assessment of aggrecan neoepitope.
Immunomodulatory effect of mesenchymal stem cells following intra-articular injection in a model of osteoarthritis: a potential role for apoptosis  P.
Dr L. S. Kim, N. D. , Dr L. J. Axelrod, N. D. , Dr P. Howard, M. D
Efficacy and safety of naproxcinod in the treatment of patients with osteoarthritis of the knee: a 13-week prospective, randomized, multicenter study 
Spinal nociceptive reflexes are sensitized in the monosodium iodoacetate model of osteoarthritis pain in the rat  S. Kelly, K.L. Dobson, J. Harris  Osteoarthritis.
The epidemiology and impact of pain in osteoarthritis
Desirable effect of combination therapy with high molecular weight hyaluronate and NSAIDs on MMP production  M. Hashizume, M. Mihara  Osteoarthritis and.
Protective effect of a new biomaterial against the development of experimental osteoarthritis lesions in rabbit: a pilot study evaluating the intra-articular.
K. Koda, K. Hyakkoku, K. Ogawa, K. Takasu, S. Imai, Y. Sakurai, M
Influence of flare design on symptomatic efficacy of non-steroidal anti-inflammatory drugs in osteoarthritis: a meta-analysis of randomized placebo-controlled.
Changes in social isolation and loneliness following total hip and knee arthroplasty: longitudinal analysis of the English Longitudinal Study of Ageing.
Preliminary assessment of the safety and efficacy of tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee: a randomized,
J. J. McDougall, S. Albacete, N. Schuelert, P. G. Mitchell, C. Lin, J
Surgically induced osteoarthritis in the rat results in the development of both osteoarthritis-like joint pain and secondary hyperalgesia  S.E. Bove,
Sustained efficacy of a single intra-articular dose of FX006 in a rat model of repeated localized knee arthritis  A. Kumar, A.M. Bendele, R.C. Blanks,
Injury of primary afferent neurons may contribute to osteoarthritis induced pain: an experimental study using the collagenase model in rats  S. Adães,
Blockade of nociceptive sensory afferent activity of the rat knee joint by the bradykinin B2 receptor antagonist fasitibant  A. Gomis, S. Meini, A. Miralles,
Successful nonoperative management of chronic osteoarthritis pain of the knee: safety and efficacy of retreatment with intra-articular hyaluronans  Mark.
P.S. McCabe, N. Maricar, M.J. Parkes, D.T. Felson, T.W. O'Neill 
Changes in biochemical markers and prediction of effectiveness of intra-articular hyaluronan in patients with knee osteoarthritis  M. Hasegawa, M.D.,
B. H. He, M. Christin, S. Mouchbahani-Constance, A. Davidova, R
A multicenter, randomized controlled trial comparing a single intra-articular injection of Gel-200, a new cross-linked formulation of hyaluronic acid,
Measuring and realizing the translational significance of preclinical in vivo studies of painful osteoarthritis  M. Hummel, G.T. Whiteside  Osteoarthritis.
The anti-NGF antibody muMab 911 both prevents and reverses pain behaviour and subchondral osteoclast numbers in a rat model of osteoarthritis pain  L.
Differences in structural and pain phenotypes in the sodium monoiodoacetate and meniscal transection models of osteoarthritis  P.I. Mapp, D.R. Sagar,
Usefulness of specific OA biomarkers, Coll2-1 and Coll2-1NO2, in the anterior cruciate ligament OA canine model  Y. Henrotin, J. Martel-Pelletier, P.
Immunomodulatory effect of mesenchymal stem cells following intra-articular injection in a model of osteoarthritis: a potential role for apoptosis  P.
Osteoarthritis and Cartilage
Preliminary assessment of the safety and efficacy of tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee: a randomized,
A quantitative approach to measure joint pain in experimental osteoarthritis—evidence of a role for nitric oxide  R.R. Castro, M.S., F.Q. Cunha, Ph.D,
Development of a novel antibody to calcitonin gene-related peptide for the treatment of osteoarthritis-related pain  R.J. Benschop, E.C. Collins, R.J.
Effects of a metalloproteinase inhibitor on osteochondral angiogenesis, chondropathy and pain behavior in a rat model of osteoarthritis  P.I. Mapp, D.A.
Dr J. Deschner, D. M. D. , Ph. D. , Dr B. Rath-Deschner, D. M. D. , Ph
Evaluation of the therapeutic effect of treatment with intra-articular hyaluronic acid in knees for Kashin-Beck disease: A meta-analysis  F.F. Yu, C.T.
Role of periostin and discoidin domain receptor-1 (DDR1) in the regulation of cartilage degeneration and expression of MMP-13  M. Attur, Q. Yang, T. Kirsch,
Risk factors associated with reduced work productivity among people with chronic knee pain  M. Agaliotis, M. Fransen, L. Bridgett, L. Nairn, M. Votrubec,
Effectiveness of thermal and athermal short-wave diathermy for the management of knee osteoarthritis: a systematic review and meta-analysis  Y. Laufer,
Efficacy of low frequency pulsed subsensory threshold electrical stimulation vs placebo on pain and physical function in people with knee osteoarthritis:
A new lipid formulation of low dose (1200mg) ibuprofen is non-inferior to high dose (2400mg) standard ibuprofen capsules in managing episodic knee pain.
The Differences of the Viscoelastic Behavior among Intra-articular Injections of Hyaluronan Formulation  H. Hoshi, K. Miyamoto  Osteoarthritis and Cartilage 
Identification and pharmacological characterization of a novel inhibitor of autotaxin in rodent models of joint pain  K. Thirunavukkarasu, C.A. Swearingen,
Who should have a joint replacement? A plea for more ‘phronesis’
C. R. Flannery, N. Moran, D. Blasioli, K. Donahue, J. Kane, T
Safety and efficacy of retreatment with a bioengineered hyaluronate for painful osteoarthritis of the knee: results of the open-label Extension Study.
Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis 
A systematic review of the efficacy and general safety of antibodies to NGF in the treatment of OA of the hip or knee  T.J. Schnitzer, J.A. Marks  Osteoarthritis.
D.J. Hunter  Osteoarthritis and Cartilage 
A comparison of intra-articular hyaluronan injection accuracy rates between three approaches based on radiographic severity of knee osteoarthritis  Y.
Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis – meta-analysis  R.R. Bannuru, N.S. Natov, U.R. Dasi,
Most patients gain weight in the 2 years after total knee arthroplasty: comparison to a healthy control group  J.A. Zeni, L. Snyder-Mackler  Osteoarthritis.
Intra-articular injections of hyaluronan solutions of different elastoviscosity reduce nociceptive nerve activity in a model of osteoarthritic knee joint.
Osteoarthritis year 2012 in review: biology
Alterations to the subchondral bone architecture during osteoarthritis: bone adaptation vs endochondral bone formation  L.G.E. Cox, C.C. van Donkelaar,
L.A. Deveza, L. Melo, T.P. Yamato, K. Mills, V. Ravi, D.J. Hunter 
The efficacy, safety and carry-over effect of diacerein in the treatment of painful knee osteoarthritis: a randomised, double-blind, NSAID-controlled.
Osteoarthritis year in review 2016: mechanics
Measurement of synovial fluid volume using urea
General Information Osteoarthritis and Cartilage
Presentation transcript:

Deficits in spontaneous burrowing behavior in the rat bilateral monosodium iodoacetate model of osteoarthritis: an objective measure of pain-related behavior and analgesic efficacy  L.A. Bryden, J.R. Nicholson, H. Doods, A. Pekcec  Osteoarthritis and Cartilage  Volume 23, Issue 9, Pages 1605-1612 (September 2015) DOI: 10.1016/j.joca.2015.05.001 Copyright © 2015 Osteoarthritis Research Society International Terms and Conditions

Fig. 1 Effect of MIA on burrowing behavior. (A) Amount of sand burrowed by naïve rats and 3 days after intra-articular (i.a.) of saline or MIA (3 mg/knee). Rats either received unilateral (right knee) or bilateral injections of saline/MIA. Data analyzed with 1-way ANOVA followed by Bonferroni's post hoc multiple comparisons (****P < 0.0001 vs sham bilateral group, n = 12 per group). (B) Concentration-response to bilateral i.a. injections of MIA 3 days after injection. Data analyzed with 1-way ANOVA followed by Bonferroni's post hoc multiple comparisons (*P < 0.05 and **P < 0.01 vs sham group, n = 10–11 per group). (C) Time-course of burrowing performance after unilateral and bilateral i.a. MIA injections (3 mg/knee). Data were analyzed with 2-way repeated measures ANOVA (MIA × time interaction: F4,48 = 12.93, P < 0.0001), followed by Bonferroni's post hoc multiple comparisons (significant differences compared with sham group on same day: **P < 0.01,****P < 0.0001, n = 12 per group). BL = baseline. Osteoarthritis and Cartilage 2015 23, 1605-1612DOI: (10.1016/j.joca.2015.05.001) Copyright © 2015 Osteoarthritis Research Society International Terms and Conditions

Fig. 2 Locomotor activity 3 days after bilateral injection of saline or 3 mg/knee MIA. Distance moved (A), rearing frequency (B) and rearing time (C) was monitored over a 30 min period. Data were analyzed with unpaired Student's t test (*P < 0.05 vs sham group, n = 8 per group). Osteoarthritis and Cartilage 2015 23, 1605-1612DOI: (10.1016/j.joca.2015.05.001) Copyright © 2015 Osteoarthritis Research Society International Terms and Conditions

Fig. 3 The effect of NSAIDs, morphine and gabapentin on burrowing performance 3 days after bilateral 3 mg/knee MIA or sham injections. Data analyzed with 2-Way ANOVA followed by Dunnett's post hoc multiple comparisons. (A) Ibuprofen (p.o.) administered 2 h before burrowing performance was measured (MIA × dose interaction: F3,66 = 2.785, P < 0.05; ##P < 0.01 vs sham vehicle, *P < 0.05, **P < 0.01 vs MIA vehicle). N = 9–10 per group. (B) Celecoxib (p.o.) administered 2 h before burrowing performance was measured (MIA × dose interaction: F3,68 = 2.82, P < 0.05; ####P < 0.0001 vs sham vehicle, *P < 0.05,**P < 0.01 vs MIA vehicle). N = 8–11 per group. (C) Morphine (s.c.) administered 1 h before burrowing performance was measured (#P < 0.05, ##P < 0.01 vs sham vehicle). N = 8–9 per group. (D) Gabapentin (p.o.) administered 2 h before burrowing performance was measured (main effect of MIA: F1,62 = 48.21, ****P < 0.0001). N = 8–9 per group. Osteoarthritis and Cartilage 2015 23, 1605-1612DOI: (10.1016/j.joca.2015.05.001) Copyright © 2015 Osteoarthritis Research Society International Terms and Conditions

Fig. 4 The effect of the anti-NGF mAb and the FAAH inhibitor PF-04457845 on burrowing performance 3 days after bilateral 3 mg/knee MIA or sham injections. Data analyzed with 2-Way ANOVA followed by Dunnett's post hoc multiple comparisons. (A) anti-NGF mAb administered 24 h before burrowing performance was measured (MIA × dose interaction: F1,28 = 7.273, P < 0.05; ###P < 0.001 vs sham vehicle, **P < 0.01 vs MIA vehicle). N = 8 per group. (B) PF-04457845 (p.o.) administered 2 h before burrowing performance was measured (main effect of MIA: F1,65 = 54.65, ****P < 0.0001). N = 8–10 per group. Osteoarthritis and Cartilage 2015 23, 1605-1612DOI: (10.1016/j.joca.2015.05.001) Copyright © 2015 Osteoarthritis Research Society International Terms and Conditions